Pulmonx (LUNG) Competitors $1.70 +0.01 (+0.59%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$1.67 -0.03 (-1.76%) As of 09/12/2025 07:25 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock LUNG vs. SKIN, CATX, OM, TLSI, MGRM, SI, INGN, STIM, NNOX, and INFUShould you be buying Pulmonx stock or one of its competitors? The main competitors of Pulmonx include Beauty Health (SKIN), Perspective Therapeutics (CATX), Outset Medical (OM), TriSalus Life Sciences (TLSI), Monogram Orthopaedics (MGRM), Shoulder Innovations (SI), Inogen (INGN), Neuronetics (STIM), Nano-X Imaging (NNOX), and InfuSystem (INFU). These companies are all part of the "medical equipment" industry. Pulmonx vs. Its Competitors Beauty Health Perspective Therapeutics Outset Medical TriSalus Life Sciences Monogram Orthopaedics Shoulder Innovations Inogen Neuronetics Nano-X Imaging InfuSystem Pulmonx (NASDAQ:LUNG) and Beauty Health (NASDAQ:SKIN) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, media sentiment, valuation, institutional ownership, risk, profitability, analyst recommendations and dividends. Which has more risk and volatility, LUNG or SKIN? Pulmonx has a beta of 0.43, indicating that its share price is 57% less volatile than the S&P 500. Comparatively, Beauty Health has a beta of 1.23, indicating that its share price is 23% more volatile than the S&P 500. Do insiders & institutionals believe in LUNG or SKIN? 91.0% of Pulmonx shares are owned by institutional investors. Comparatively, 93.3% of Beauty Health shares are owned by institutional investors. 6.8% of Pulmonx shares are owned by company insiders. Comparatively, 41.0% of Beauty Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Do analysts prefer LUNG or SKIN? Pulmonx presently has a consensus target price of $7.66, indicating a potential upside of 350.84%. Beauty Health has a consensus target price of $2.63, indicating a potential upside of 3.75%. Given Pulmonx's stronger consensus rating and higher possible upside, analysts plainly believe Pulmonx is more favorable than Beauty Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Pulmonx 0 Sell rating(s) 4 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.56Beauty Health 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Does the media favor LUNG or SKIN? In the previous week, Beauty Health had 12 more articles in the media than Pulmonx. MarketBeat recorded 17 mentions for Beauty Health and 5 mentions for Pulmonx. Beauty Health's average media sentiment score of 0.95 beat Pulmonx's score of 0.80 indicating that Beauty Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Pulmonx 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Beauty Health 9 Very Positive mention(s) 3 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Which has preferable earnings & valuation, LUNG or SKIN? Beauty Health has higher revenue and earnings than Pulmonx. Beauty Health is trading at a lower price-to-earnings ratio than Pulmonx, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPulmonx$90.55M0.76-$56.39M-$1.43-1.19Beauty Health$334.30M0.96-$29.10M-$0.28-9.04 Is LUNG or SKIN more profitable? Beauty Health has a net margin of -6.13% compared to Pulmonx's net margin of -62.88%. Beauty Health's return on equity of -32.82% beat Pulmonx's return on equity.Company Net Margins Return on Equity Return on Assets Pulmonx-62.88% -69.76% -36.26% Beauty Health -6.13%-32.82%-2.96% SummaryBeauty Health beats Pulmonx on 12 of the 16 factors compared between the two stocks. Get Pulmonx News Delivered to You Automatically Sign up to receive the latest news and ratings for LUNG and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LUNG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LUNG vs. The Competition Export to ExcelMetricPulmonxMEDICAL INFO SYS IndustryMedical SectorNASDAQ ExchangeMarket Cap$68.86M$2.18B$5.87B$10.13BDividend YieldN/AN/A5.68%4.60%P/E Ratio-1.1935.7174.5225.93Price / Sales0.7610.23516.21181.52Price / CashN/A58.3137.5660.44Price / Book0.7811.6512.166.29Net Income-$56.39M-$63.67M$3.28B$270.77M7 Day Performance-2.30%-0.25%0.78%3.84%1 Month Performance10.39%2.21%4.87%4.85%1 Year Performance-79.54%35.29%60.72%26.00% Pulmonx Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LUNGPulmonx3.7081 of 5 stars$1.70+0.6%$7.66+350.8%-79.2%$68.86M$90.55M-1.19250SKINBeauty Health0.4917 of 5 stars$2.33+13.7%$2.63+12.7%+73.3%$259.99M$334.30M-8.321,030CATXPerspective Therapeutics1.7209 of 5 stars$3.43-0.9%$12.56+266.1%-78.0%$254.72MN/A0.0070OMOutset Medical2.3092 of 5 stars$13.81-1.4%$24.67+78.6%+102.6%$248.90M$113.69M-0.68520Positive NewsTLSITriSalus Life Sciences2.9422 of 5 stars$5.01+0.4%$10.75+114.6%-13.8%$248.84M$29.43M-4.25106MGRMMonogram Orthopaedics1.8542 of 5 stars$5.75+0.7%$5.40-6.1%+82.5%$232.01MN/A-11.5028Short Interest ↓SIShoulder Innovations3.322 of 5 stars$16.03+7.9%$19.60+22.3%N/A$226.14MN/A-0.5461News CoverageAnalyst ForecastQuiet Period ExpirationINGNInogen4.1865 of 5 stars$8.45+4.2%$11.00+30.2%-24.2%$219.30M$335.70M-7.971,030Positive NewsSTIMNeuronetics2.0452 of 5 stars$3.37+4.3%$7.00+107.7%+323.0%$213.58M$74.89M-2.98180Positive NewsNNOXNano-X Imaging2.946 of 5 stars$4.02+8.9%$8.50+111.4%-37.1%$213.21M$11.28M-4.47190INFUInfuSystem3.3545 of 5 stars$10.26+1.0%$12.50+21.8%+54.4%$209.57M$139.89M171.03410Positive News Related Companies and Tools Related Companies Beauty Health Competitors Perspective Therapeutics Competitors Outset Medical Competitors TriSalus Life Sciences Competitors Monogram Orthopaedics Competitors Shoulder Innovations Competitors Inogen Competitors Neuronetics Competitors Nano-X Imaging Competitors InfuSystem Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LUNG) was last updated on 9/13/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pulmonx Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Pulmonx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LUNG Stock Alerts